1. Welcome to SportsJournalists.com, a friendly forum for discussing all things sports and journalism.

    Your voice is missing! You will need to register for a free account to get access to the following site features:
    • Reply to discussions and create your own threads.
    • Access to private conversations with other members.
    • Fewer ads.

    We hope to see you as a part of our community soon!

When Drug Companies Are Hazardous To Your Health

Discussion in 'Sports and News' started by WCIBN, Feb 2, 2014.

  1. WCIBN

    WCIBN Active Member

    GlaxoSmithKline discontinues production of "wonder cancer drug" Bexxar because it wasn't earning the company enough money.

    How much, if any, of a PR disaster will this be for the company and Big Pharma in general?



    When Drug Companies Are Hazardous To Your Health: Lifesaving Cancer Drug Bexxar Discontinued By GlaxoSmithKline (NYSE:GSK), Experimental Drugs Withheld:

    http://www.ibtimes.com/when-drug-companies-are-hazardous-your-health-lifesaving-cancer-drug-bexxar-discontinued-1551568


    Wonder Cancer Drug Bexxar Discontinued Because Of Low Profits:

    http://www.opposingviews.com/i/health/conditions/cancer/wonder-cancer-drug-bexxar-discontinued-because-low-profits
     
  2. The Big Ragu

    The Big Ragu Moderator Staff Member

    This is really old news. GSK announced this at least 6 months ago. The lymphoma patient that was quoted in the article must have driven a new story with what was a pretty unbalanced slant.

    Hardly anyone used Bexxar. Which is why GSK decided to stop manufacturing it. Supply and demand.

    The facts: Bexxar was prescribed to fewer than 75 patients in the U.S. in 2012 (GSK announced they were discontinuing it in the middle of last year, and released that number for its 2012 sales when it did). Since 2008, only 18 patients in Canada had been prescribed it. Oncologists don't prescribe it, and there are a number of other treatments available for Non-Hodgkin's Lymphoma that are more popular. Lots of drugs have gone that way. Would you continue to manufacture something that nobody buys?
     
  3. LongTimeListener

    LongTimeListener Well-Known Member

    We're in newspapers, man.
     
  4. Bradley Guire

    Bradley Guire Well-Known Member

    Spit take.
     
  5. Rusty Shackleford

    Rusty Shackleford Active Member

    Yep, we may only be 34 days in, but that's Post of the Year quality right there.
     
  6. WCIBN

    WCIBN Active Member


    I think manufacturers of cancer reducing drugs should be held to a different standard than those who make a product like New Coke, typewriters, VCRs or 8-tracks. If GSK thinks the production of Bexxar isn't worth their time, they should sell their patent to another pharmaceutical company or license the manufacturing rights to others or give up their right to exclusively manufacturer the drug. Don't just stop production completely, lock up the formula in a safe and use your patent to prevent others from producing the drug.

    Now I'm biased on this since I know someone who ten years ago received the Bexxar treatment and has been considered 'cancer-free' since then. Why are there so few people receiving this treatment now? Probably a combination of Medicare's 2007 decision to reduce their reimbursement rate for this drug, insurance companies doing the same and in many cases forcing patients to undergo other 'more cost-effective' treatments first before making Bexxar available to their insurees and some oncologists not willing to prescribe the treatment since they may not be qualified to administer the treatment themselves. see: http://www.medicineatmichigan.org/magazine/2011/summer/wherecures/bexxar.asp

    I know if I, or some one close to me, is diagnosed with non-Hodgkin's lymphoma, I'd be livid that Bexxar isn't available as a treatment option because GSK stopped production of it "because it wasn't profitable enough" and they wouldn't let anyone else produce it either. IMO, drug companies should have to manufacture their patented drugs or forfeit their patent on them. If there is limited demand for the product, manufacture it on a on-demand basis.
     
  7. doctorquant

    doctorquant Well-Known Member

    A more balanced take:

    http://www.xconomy.com/national/2013/08/26/why-good-drugs-sometimes-fail-in-the-market-the-bexxar-story/

    With a pretty telling quote:

     
  8. WCIBN

    WCIBN Active Member


    this former Newsweek journalist/cancer survivor/Bexxar patient has a different view:

    http://therenodispatch.blogspot.com/2013/08/breaking-exclusive-lifesaving-cancer.html
     
  9. doctorquant

    doctorquant Well-Known Member

    I'm sure he's found all the flaws in this study:

    https://ash.confex.com/ash/2011/webprogram/Paper39037.html

    [​IMG]

    After all, what the eff do these folks know?
     
    Last edited by a moderator: Dec 15, 2014
  10. YankeeFan

    YankeeFan Well-Known Member

    If doctors aren't prescribing it, why are we blaming GSK?
     
  11. doctorquant

    doctorquant Well-Known Member

    Because it's an EEVUL CORPORATION!!!1!!!
     
  12. RickStain

    RickStain Well-Known Member

    Well, on the one hand we have a scientific study. On the other hand, we have a personal anecdote.

    I hate the fact that for the vast majority of the human race, there is some confusion as to which should be more compelling.
     
Draft saved Draft deleted

Share This Page